| | Nonadjusted | Model 1 | Model 2 | HR (95% CIs) | | for trend | HR (95% CIs) | | for trend | HR (95% CIs) | | for trend |
| 30-day all-cause mortality | Tertile 1 () | 1.0 (ref) | | <0.001 | 1.0 (ref) | | <0.001 | 1.0 (ref) | | <0.001 | Tertile 2 () | 2.449 (1.887, 3.179) | <0.001 | | 2.185 (1.680, 2.842) | <0.001 | | 1.589 (1.212, 2.084) | 0.001 | | Tertile 3 () | 3.929 (3.066, 5.035) | <0.001 | | 3.387 (2.635, 4.353) | <0.001 | | 1.924 (1.471, 2.516) | <0.001 | | Continuous | 1.056 (1.048, 1.065) | <0.001 | | 1.051 (1.042, 1.060) | <0.001 | | 1.032 (1.021, 1.043) | <0.001 | | 90-day all-cause mortality | Tertile 1 () | 1.0 (ref) | | <0.001 | 1.0 (ref) | | <0.001 | 1.0 (ref) | | <0.001 | Tertile 2 () | 2.422 (1.952, 3.007) | <0.001 | | 2.177 (1.751, 2.707) | <0.001 | | 1.701 (1.361, 2.126) | <0.001 | | Tertile 3 () | 4.006 (3.262, 4.919) | <0.001 | | 3.485 (2.831, 4.290) | <0.001 | | 2.053 (1.646, 2.560) | <0.001 | | Continuous | 1.059 (1.051, 1.066) | <0.001 | | 1.054 (1.046, 1.061) | <0.001 | | 1.032 (1.023, 1.040) | <0.001 | | 365-day all-cause mortality | Tertile 1 () | 1.0 (ref) | | <0.001 | 1.0 (ref) | | <0.001 | 1.0 (ref) | | <0.001 | Tertile 2 () | 2.286 (1.910, 2.735) | <0.001 | | 2.039 (1.701, 2.444) | <0.001 | | 1.629 (1.354, 1.960) | <0.001 | | Tertile 3 () | 3.823 (3.223, 4.535) | <0.001 | | 3.315 (2.789, 3.940) | <0.001 | | 2.063 (1.717, 2.480) | <0.001 | | Continuous | 1.058 (1.052, 1.065) | <0.001 | | 1.053 (1.046, 1.060) | <0.001 | | 1.032 (1.024, 1.040) | <0.001 | |
|
|
HR: hazard ratio; CI: confidence interval. Models were derived from Cox proportional hazard regression models. Nonadjusted model, adjusted for none. Adjust I model, adjusted for age, ethnicity, and gender. Adjust II model, adjusted for age, ethnicity, gender, ICU LOS, BMI, SBP, DBP, HR, MI, DM, hypercholesterolemia, prior MI, congestive heart failure, atrial fibrillation, hypertension, beta-blockers, oral anticoagulant, ACEI, ARB, blood urea nitrogen, glucose, platelet, WBC, ALT, INR, LDL-C, HDL-C, TC, TnT, CRP, SOFA, and SAPS II.
|